搜索筛选:
搜索耗时0.0862秒,为你在为你在102,285,761篇论文里面共找到 41 篇相符的论文内容
发布年度:
[期刊论文] 作者：Yuankai Shi,Ping Zhou,Xiaohong,
来源：癌症：英文版 年份：2015
Ovarian tumors comprise a heterogeneous group of lesions, displaying distinct tumor pathology and oncogenic potentiel. These tumors are subdivided into three ma...
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary
[期刊论文] 作者：Yuankai Shi,Ying Han,Jianliang,
来源：中国癌症研究:英文版 年份：2019
Objective: To explore the clinicobiologic features and outcomes of diffuse large B-cell lymphoma(DLBCL)patients in China according to the primary site.Methods:...
Autologous peripheral blood stem cell mobilization following dose-adjusted cyclophosphamide, doxorub
[期刊论文] 作者：Yuankai Shi,Ping Zhou,Xiaohong,
来源：黑龙江科技学院学报 年份：2015
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7...
[期刊论文] 作者：Bo Jia,Yuankai Shi,Suyi Kang,S,
来源：中国癌症研究：英文版 年份：2015
Background:The role of rituximab in combination with CHOP regimen in patients with stage I diffuse large B-cell lymphoma(DLBCL) remains to be defined.We aimed t...
[期刊论文] 作者：Xingsheng Hu,Lin Wang,Lin Lin,Yuankai Shi,,
来源：The Chinese-German Journal of Clinical Oncology 年份：2014
Histone deacetylase(HDAC) inhibitors, which represent a structurally diverse group of molecules, have emerged as a novel therapeutic class of molecules with sig...
[会议论文] 作者：Shuxia Liu,Qiaoyun Tan,Yuanyuan Song,Yuankai Shi,Xiaohong Han,
来源：2019中国肿瘤学大会 年份：2019
Objective Serum autoantibodies against tumor-associated antigens have been found and extensively studied in different types of cancer,which were deemed as promising cancer biomarkers in diagnosis,trea...
Phase Ⅰ dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unrese
[期刊论文] 作者：Yihebali Chi,Jianliang Yang,Sheng Yang,Yongkun Sun,Bo Jia,Yuankai Shi,
来源：中国癌症研究（英文版） 年份：2015
...
PhaseⅠdose-finding study of sorafenib with FOLFOX4 as firstline treatment in patients with unresecta
[期刊论文] 作者：Yihebali Chi,Jianliang Yang,Sheng Yang,Yongkun Sun,Bo Jia,Yuankai Shi,,
来源：Chinese Journal of Cancer Research 年份：2015
Objective: To determine the maximum tolerated dose(MTD), dose-limiting toxicity(DLT) and efficacy of sorafenib in combination with FOLFOX4(oxaliplatin/leucovori...
A new method of UPLC-MS/MS assay for determinations of chlorogenic acid concentrations in human plas
[会议论文] 作者：Shuxia Liu,Ning Li,Sheng Yang,Yuanyuan Song,Yuankai Shi,Xiaohong Han,
来源：2019中国肿瘤学大会 年份：2019
...
A phase Ⅰ trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combinatio
[期刊论文] 作者：Xingsheng Hu,Lin Wang,Lin Lin,Xiaohong Han,Guifang Dou,Zhiyun Meng,Yuankai Shi,,
来源：Chinese Journal of Cancer Research 年份：2016
Objective: This phase Ⅰ study was to evaluate safety, maximum tolerated dose, pharmacokinetics and preliminary antitumor activity of chidamide, a novel subtype...
Autoantibodies indicating diagnostic or prognostic value in NSCLC patients were identified by protei
[会议论文] 作者：Rongrong Luo,Caixia Liang,Jiarui Yao,Di Wu,Zhishang Zhang,Yuankai Shi,Xiaohong Han,
来源：2019中国肿瘤学大会 年份：2019
Objective Non-small cell lung cancer(NSCLC)accounts for 85%of lung cancer,the leading cause of cancer dearth worldwide.Autoantibodies(AAbs)have been recently recognized as auxiliary diagnostic biomark...
[期刊论文] 作者：Bo Jia,Yuankai Shi,Suyi Kang,Sheng Yang,Shaoxuan Hu,Yexiong Li,Mei Dong,
来源：中国癌症研究（英文版） 年份：2015
...
Clinical features, survival and prognostic factors of primary testicular diffuse large B-cell lympho
[期刊论文] 作者：Bo Jia,Yuankai Shi,Mei Dong,Fengyi Feng,Sheng Yang,Hua Lin,Liqiang Zhou,
来源：中国癌症研究（英文版） 年份：2014
...
[会议论文] 作者：Li Ma,Chunling Zhang,Jiarui Yao,Yuankai Shi,Hongying Yang,Fang Wang,Jia Li,Xiaohong Han,
来源：第六届中国肿瘤内科大会 年份：2012
...
[会议论文] 作者：Li Yang,Xinge Cui,Min Li,Huwei Liu,Ningning Zhang,Xiaohong Han,Yu Bai,Yuankai Shi,
来源：43rd International Symposium on High Performance Liquid Phas 年份：2015
...
[会议论文] 作者：Li Ma,Hongying Yang,Jia Li,Fang Wang,Chunling Zhang,Jiarui Yao,Xiaohong Han,Yuankai Shi,
来源：第六届中国肿瘤内科大会 年份：2012
Background: The measurement of the human epidermal growth factor receptor 2 (HER2) protein in the serum of metastatic breast cancer patients has now been reported, but there are no consistent data to...
[会议论文] 作者：Lei Zhang,Rongrong Luo,Lin Wang,Jiarui Yao,Di Wu,Zhishang Zhang,Xiaohong Han,Yuankai Shi,
来源：2019中国肿瘤学大会 年份：2019
Objective Metabolites and somatic mutations involved in the EGFR-TKI efficacy remains unclear in the first-line non-small cell lung cancer(NSCLC)patients with EGFR sensitizing mutation.Here we perform...
[会议论文] 作者：Huwei Liu,Li Yang,Xinge Cui,Ningning Zhang,Min Li,Yu Bai,Xiaohong Han,Yuankai Shi,
来源：43rd International Symposium on High Performance Liquid Phas 年份：2015
Abnormal lipid metabolism is a common feature in most solid tumours,which occurs in early stage of the tumour progression [1]....
A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony
[期刊论文] 作者：Yan Qin,Xiaohong Han,Lin Wang,Ping Du,Jiarui Yao,Di Wu,Yuanyuan Song,Shuxiang Zhang,Le Tang,Yuankai Shi,
来源：Chinese Journal of Cancer Research 年份：2017
Objective: The recommended dose of prophylactic pegylated recombinant human granulocyte-colony stimulating factor(PEG rhG-CSF) is 100 μg/kg once per cycle for...
ALK gene expression status in pleural effusion predicts tumor responsiveness to crizotinib in Chines
[期刊论文] 作者：Zheng Wang,Xiaonan Wu,Xiaohong Han,Gang Cheng,Xinlin Mu,Yuhui Zhang,Di Cui,Chang Liu,Dongge Liu,Yuankai Shi,
来源：Chinese Journal of Cancer Research 年份：2016
Objective: The relationship between anaplastic lymphoma kinase(ALK) expression in malignant pleural effusion(MPE) samples detected only by Ventana immunohistoch...
相关搜索：
